Omega Therapeutics, Inc.
OMGA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$97,428 | -$102,701 | -$68,280 | -$29,447 |
| Dep. & Amort. | $6,771 | $5,190 | $1,387 | $1,146 |
| Deferred Tax | $0 | $0 | $1,332 | $25 |
| Stock-Based Comp. | $8,793 | $7,753 | $3,184 | $637 |
| Change in WC | -$9,366 | -$9,882 | $4,662 | $1,565 |
| Other Non-Cash | -$280 | $1,125 | $106 | -$59 |
| Operating Cash Flow | -$91,510 | -$98,515 | -$57,609 | -$26,133 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,869 | -$1,380 | -$1,467 | -$1,808 |
| Net Acquisitions | $0 | $16,680 | $0 | $0 |
| Inv. Purchases | -$19,768 | -$57,415 | -$38,932 | $0 |
| Inv. Sales/Matur. | $69,502 | $40,735 | $0 | $0 |
| Other Inv. Act. | $650 | -$16,680 | -$38,932 | $0 |
| Investing Cash Flow | $47,515 | -$18,060 | -$40,399 | -$1,808 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,623 | $0 | $8,000 | $0 |
| Stock Issued | $40,000 | $708 | $131,238 | $48,618 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $200 | $708 | $122,301 | $48,618 |
| Financing Cash Flow | $41,823 | $708 | $261,539 | $48,618 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,172 | -$115,867 | $163,531 | $20,677 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,956 | $186,823 | $23,292 | $2,615 |
| End Cash | $68,784 | $70,956 | $186,823 | $23,292 |
| Free Cash Flow | -$94,379 | -$99,895 | -$59,076 | -$27,941 |